Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients

Three patients with hematologic relapse after bone marrow transplantation for chronic myelogenous leukemia were treated with interferon alpha and transfusion of viable donor buffy coat. All had complete hematologic and cytogenetic remission, which persisted 32 to 91 weeks after treatment. In two pat... View More